Ignite Creation Date:
2024-07-17 @ 11:34 AM
Last Modification Date:
2024-10-26 @ 3:32 PM
Study NCT ID:
NCT06463873
Status:
RECRUITING
Last Update Posted:
2024-07-09
First Post:
2024-06-10
Brief Title:
Study of OmniGraft in Simultaneous Pancreas Kidney Recipients
Sponsor:
University of Miami
Organization:
University of Miami
Study Overview
Official Title:
A Pilot Study of OmniGraft in Simultaneous Pancreas Kidney Recipients
Status:
RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this research is learn about how OmniGraf works in kidney pancreas transplant patients Also to analyze the performance characteristics of OmniGrafTM TruGraf Gene Expression Profiling GEP and T Cell Receptor Alpha Constant TRAC dd-cfDNA in a population of simultaneous kidney pancreas transplants as a part of routine surveillance as well as a part of the workup for patients clinically suspected to have rejection of the kidney andor pancreas
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None